- Home
- NBTX vs JOF Comparison
NBTX vs JOF Comparison
Compare NBTX & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- JOF
- Stock Information
- Founded
- NBTX 2003
- JOF 1990
- Country
- NBTX France
- JOF Japan
- Employees
- NBTX N/A
- JOF N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- JOF Trusts Except Educational Religious and Charitable
- Sector
- NBTX Health Care
- JOF Finance
- Exchange
- NBTX Nasdaq
- JOF Nasdaq
- Market Cap
- NBTX 201.9M
- JOF 213.4M
- IPO Year
- NBTX 2020
- JOF N/A
- Fundamental
- Price
- NBTX $3.26
- JOF $7.57
- Analyst Decision
- NBTX Strong Buy
- JOF
- Analyst Count
- NBTX 1
- JOF 0
- Target Price
- NBTX $12.00
- JOF N/A
- AVG Volume (30 Days)
- NBTX 64.6K
- JOF 43.9K
- Earning Date
- NBTX 12-31-2024
- JOF 01-01-0001
- Dividend Yield
- NBTX N/A
- JOF 3.33%
- EPS Growth
- NBTX N/A
- JOF N/A
- EPS
- NBTX N/A
- JOF N/A
- Revenue
- NBTX $45,220,186.00
- JOF N/A
- Revenue This Year
- NBTX N/A
- JOF N/A
- Revenue Next Year
- NBTX N/A
- JOF N/A
- P/E Ratio
- NBTX N/A
- JOF N/A
- Revenue Growth
- NBTX 526.17
- JOF N/A
- 52 Week Low
- NBTX $2.76
- JOF $6.64
- 52 Week High
- NBTX $8.96
- JOF $8.04
- Technical
- Relative Strength Index (RSI)
- NBTX 42.55
- JOF 35.02
- Support Level
- NBTX $3.18
- JOF $7.84
- Resistance Level
- NBTX $3.69
- JOF $7.98
- Average True Range (ATR)
- NBTX 0.27
- JOF 0.13
- MACD
- NBTX 0.07
- JOF -0.05
- Stochastic Oscillator
- NBTX 56.45
- JOF 12.50
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.